Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. [electronic resource]
Producer: 19931012Description: 193-202 p. digitalISSN:- 0936-3076
- Aged
- Alzheimer Disease -- cerebrospinal fluid
- Biogenic Monoamines -- cerebrospinal fluid
- Double-Blind Method
- Female
- Humans
- Monoamine Oxidase Inhibitors -- adverse effects
- Norepinephrine -- cerebrospinal fluid
- Pilot Projects
- Psychiatric Status Rating Scales
- Selegiline -- adverse effects
- Tryptophan -- cerebrospinal fluid
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.